Interpath is an innovative company specialising in research, development and marketing of products for the treatment of cellular and tissue inflammation. Interpath takes an evidence based medicine approach to its research and development. This involves the development of safe, clinically proven products which not only provide symptomatic relief but which also halt underlying disease processes. Interpath's primary objective is: To develop safe effective products for the prevention and treatment of inflammatory disorders for the human and veterinary health markets worldwide.
Looking for a particular INTERPATH NZ LIMITED employee's phone or email?
INTERPATH NZ LIMITED Questions
The INTERPATH NZ LIMITED annual revenue was $6 million in 2026.
Rebecca Britton is the CEO of INTERPATH NZ LIMITED.
10 people are employed at INTERPATH NZ LIMITED.
INTERPATH NZ LIMITED is based in Ballarat, Victoria.
The NAICS codes for INTERPATH NZ LIMITED are [32541, 32, 3254, 325].
The SIC codes for INTERPATH NZ LIMITED are [2834, 28, 283].
Top INTERPATH NZ LIMITED Employees
-
Rebecca Britton
Chief Executive Officer at INTERPATH NZ LIMITED
Melbourne, VIC, AU1 -
21
-
Lisa Turner
Accounts Assistant at INTERPATH NZ LIMITED
Melbourne, VIC, AU1 -
Jacob Goodman
Purchasing and Scheduling Manager at INTERPATH NZ LIMITED
Ballarat Central, VIC, AU1 -
Ashley Bright
Global Brand Manager -Epijoint at INTERPATH NZ LIMITED
Melbourne, VIC, AU21 -
Havey Manion
Sales Manager at INTERPATH NZ LIMITED
Pilot Point, TX, US1 -
Alexandra Medved
Account Manager at INTERPATH NZ LIMITED
Melbourne, VIC, AU2 -
21
